Axogen, Inc.
For the period ended Mar 31, 2026. Filed Apr 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended March 31, 2026, our Section 16 officers and directors adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K as noted below.
| Name and Title | Action | Date | Trading Arrangement | Aggregate Number of Securities to be Sold | Expiration Date |
|---|---|---|---|---|---|
| Rule 10b5-1 (1) · Non-Rule 10b5-1 (2) | |||||
| Marc Began, Executive Vice President, General Counsel and Chief Compliance Officer | Adopt | 3/11/2026 | X | 67,500 | 12/31/2026 |
(1)Intended to satisfy the affirmative defense of Rule 10b5-1(c).
(2)Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.